NO943749L - Sammensetning for profylakse og behandling av myopi - Google Patents

Sammensetning for profylakse og behandling av myopi

Info

Publication number
NO943749L
NO943749L NO943749A NO943749A NO943749L NO 943749 L NO943749 L NO 943749L NO 943749 A NO943749 A NO 943749A NO 943749 A NO943749 A NO 943749A NO 943749 L NO943749 L NO 943749L
Authority
NO
Norway
Prior art keywords
myopia
treatment
prophylaxis
composition
effects
Prior art date
Application number
NO943749A
Other languages
English (en)
Norwegian (no)
Other versions
NO943749D0 (no
Inventor
Toshiro Shigemitsu
Noriko Watanabe
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Publication of NO943749D0 publication Critical patent/NO943749D0/no
Publication of NO943749L publication Critical patent/NO943749L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/436Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having oxygen as a ring hetero atom, e.g. rapamycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0048Eye, e.g. artificial tears

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Inorganic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO943749A 1993-10-07 1994-10-06 Sammensetning for profylakse og behandling av myopi NO943749L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP25138393 1993-10-07
JP1253794 1994-02-04

Publications (2)

Publication Number Publication Date
NO943749D0 NO943749D0 (no) 1994-10-06
NO943749L true NO943749L (no) 1995-04-10

Family

ID=26348167

Family Applications (1)

Application Number Title Priority Date Filing Date
NO943749A NO943749L (no) 1993-10-07 1994-10-06 Sammensetning for profylakse og behandling av myopi

Country Status (18)

Country Link
US (1) US5519030A (de)
EP (1) EP0647445B1 (de)
KR (1) KR100193406B1 (de)
CN (1) CN1108095A (de)
AT (1) ATE175350T1 (de)
AU (1) AU677860B2 (de)
BR (1) BR9404007A (de)
CA (1) CA2133805A1 (de)
CZ (1) CZ244994A3 (de)
DE (1) DE69415757T2 (de)
ES (1) ES2126039T3 (de)
FI (1) FI944687A (de)
HU (1) HUT71112A (de)
NO (1) NO943749L (de)
NZ (1) NZ264616A (de)
PL (1) PL305352A1 (de)
SK (1) SK121394A3 (de)
TW (1) TW282471B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR980008226A (ko) * 1996-07-05 1998-04-30 다케다 쿠니오 시각기능장애의 예방 및 치료제
SE0002211D0 (sv) * 2000-06-13 2000-06-13 Synphora Ab Methods and compositions for prevention of myopia
MD38Z5 (ro) * 2009-02-20 2010-02-28 Татьяна ГИДИРИМСКИЙ Metodă de corecţie a vederii la slab văzători
WO2013022801A1 (en) 2011-08-05 2013-02-14 Forsight Vision4, Inc. Small molecule delivery with implantable therapeutic device
AU2011329656B2 (en) 2010-11-19 2017-01-05 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
US9968603B2 (en) 2013-03-14 2018-05-15 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US9474756B2 (en) 2014-08-08 2016-10-25 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4728509A (en) * 1985-08-19 1988-03-01 Takeda Chemical Industries, Ltd. Aqueous liquid preparation
JPH06110587A (ja) * 1992-09-28 1994-04-22 Omron Corp 自動取引き機の電源制御方法とその装置

Also Published As

Publication number Publication date
HUT71112A (en) 1995-11-28
ES2126039T3 (es) 1999-03-16
NO943749D0 (no) 1994-10-06
AU677860B2 (en) 1997-05-08
CZ244994A3 (en) 1995-04-12
AU7441794A (en) 1995-04-27
DE69415757D1 (de) 1999-02-18
CN1108095A (zh) 1995-09-13
KR100193406B1 (ko) 1999-06-15
CA2133805A1 (en) 1995-04-08
HU9402883D0 (en) 1995-01-30
PL305352A1 (en) 1995-04-18
DE69415757T2 (de) 1999-06-10
ATE175350T1 (de) 1999-01-15
KR950010896A (ko) 1995-05-15
FI944687A (fi) 1995-04-08
NZ264616A (en) 1997-06-24
US5519030A (en) 1996-05-21
EP0647445A1 (de) 1995-04-12
FI944687A0 (fi) 1994-10-06
BR9404007A (pt) 1995-06-13
SK121394A3 (en) 1995-07-11
EP0647445B1 (de) 1999-01-07
TW282471B (de) 1996-08-01

Similar Documents

Publication Publication Date Title
CA2029420A1 (en) Pharmaceutical compositions and methods for inhibition of maillard's reaction
ATE225770T1 (de) Difluoroprostaglandin-derivate und ihre anwendung
HK162895A (en) A locally administrable therapeutic composition for inflammatory disease
DK0773226T3 (da) Propiophenonderivater og fremgangsmåder til fremstilling deraf
GR3032122T3 (en) Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones.
AU2868689A (en) Use of 1,4-disubstituted-piperidinyl compounds in the manufacture of a medicament for the treatment of insomnia
GR3005990T3 (de)
NO943749L (no) Sammensetning for profylakse og behandling av myopi
MD1560G2 (ro) Compuşi ciclici, compoziţii farmaceutice pe baza lor şi metode de tratament al infecţiilor sau bolilor provocate de retrovirusuri
NO940777L (no) Anvendelse av et pregnanderivat
AU4720389A (en) N-pyridinyl-9h-carbazol-9-amines, a process their preparation and their use as medicaments
ES2087173T3 (es) Uso de derivados de piridoindol en el tratamiento de enfermedades isquemicas.
EP0301466A3 (en) Uricosuric composition
RU94035672A (ru) Композиция для профилактики и лечения близорукости, способ ее получения
TH17660EX (th) สารผสมสำหรับป้องกันและรักษาสายตาสั้น
ATE81466T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur prophylaxe und zur behandlung von herzinsuffizienz.
TH17660A (th) สารผสมสำหรับป้องกันและรักษาสายตาสั้น
ATE81465T1 (de) Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten.